-
Guidelines and Evaluation of Clinical Explainable AI in Medical Image Analysis
Authors:
Weina Jin,
Xiaoxiao Li,
Mostafa Fatehi,
Ghassan Hamarneh
Abstract:
Explainable artificial intelligence (XAI) is essential for enabling clinical users to get informed decision support from AI and comply with evidence-based medical practice. Applying XAI in clinical settings requires proper evaluation criteria to ensure the explanation technique is both technically sound and clinically useful, but specific support is lacking to achieve this goal. To bridge the rese…
▽ More
Explainable artificial intelligence (XAI) is essential for enabling clinical users to get informed decision support from AI and comply with evidence-based medical practice. Applying XAI in clinical settings requires proper evaluation criteria to ensure the explanation technique is both technically sound and clinically useful, but specific support is lacking to achieve this goal. To bridge the research gap, we propose the Clinical XAI Guidelines that consist of five criteria a clinical XAI needs to be optimized for. The guidelines recommend choosing an explanation form based on Guideline 1 (G1) Understandability and G2 Clinical relevance. For the chosen explanation form, its specific XAI technique should be optimized for G3 Truthfulness, G4 Informative plausibility, and G5 Computational efficiency. Following the guidelines, we conducted a systematic evaluation on a novel problem of multi-modal medical image explanation with two clinical tasks, and proposed new evaluation metrics accordingly. Sixteen commonly-used heatmap XAI techniques were evaluated and found to be insufficient for clinical use due to their failure in G3 and G4. Our evaluation demonstrated the use of Clinical XAI Guidelines to support the design and evaluation of clinically viable XAI.
△ Less
Submitted 8 December, 2022; v1 submitted 16 February, 2022;
originally announced February 2022.
-
Dementia Severity Classification under Small Sample Size and Weak Supervision in Thick Slice MRI
Authors:
Reza Shirkavand,
Sana Ayromlou,
Soroush Farghadani,
Maedeh-sadat Tahaei,
Fattane Pourakpour,
Bahareh Siahlou,
Zeynab Khodakarami,
Mohammad H. Rohban,
Mansoor Fatehi,
Hamid R. Rabiee
Abstract:
Early detection of dementia through specific biomarkers in MR images plays a critical role in developing support strategies proactively. Fazekas scale facilitates an accurate quantitative assessment of the severity of white matter lesions and hence the disease. Imaging Biomarkers of dementia are multiple and comprehensive documentation of them is time-consuming. Therefore, any effort to automatica…
▽ More
Early detection of dementia through specific biomarkers in MR images plays a critical role in developing support strategies proactively. Fazekas scale facilitates an accurate quantitative assessment of the severity of white matter lesions and hence the disease. Imaging Biomarkers of dementia are multiple and comprehensive documentation of them is time-consuming. Therefore, any effort to automatically extract these biomarkers will be of clinical value while reducing inter-rater discrepancies. To tackle this problem, we propose to classify the disease severity based on the Fazekas scale through the visual biomarkers, namely the Periventricular White Matter (PVWM) and the Deep White Matter (DWM) changes, in the real-world setting of thick-slice MRI. Small training sample size and weak supervision in form of assigning severity labels to the whole MRI stack are among the main challenges. To combat the mentioned issues, we have developed a deep learning pipeline that employs self-supervised representation learning, multiple instance learning, and appropriate pre-processing steps. We use pretext tasks such as non-linear transformation, local shuffling, in- and out-painting for self-supervised learning of useful features in this domain. Furthermore, an attention model is used to determine the relevance of each MRI slice for predicting the Fazekas scale in an unsupervised manner. We show the significant superiority of our method in distinguishing different classes of dementia compared to state-of-the-art methods in our mentioned setting, which improves the macro averaged F1-score of state-of-the-art from 61% to 76% in PVWM, and from 58% to 69.2% in DWM.
△ Less
Submitted 18 March, 2021;
originally announced March 2021.
-
Artificial Intelligence in Glioma Imaging: Challenges and Advances
Authors:
Weina Jin,
Mostafa Fatehi,
Kumar Abhishek,
Mayur Mallya,
Brian Toyota,
Ghassan Hamarneh
Abstract:
Primary brain tumors including gliomas continue to pose significant management challenges to clinicians. While the presentation, the pathology, and the clinical course of these lesions are variable, the initial investigations are usually similar. Patients who are suspected to have a brain tumor will be assessed with computed tomography (CT) and magnetic resonance imaging (MRI). The imaging finding…
▽ More
Primary brain tumors including gliomas continue to pose significant management challenges to clinicians. While the presentation, the pathology, and the clinical course of these lesions are variable, the initial investigations are usually similar. Patients who are suspected to have a brain tumor will be assessed with computed tomography (CT) and magnetic resonance imaging (MRI). The imaging findings are used by neurosurgeons to determine the feasibility of surgical resection and plan such an undertaking. Imaging studies are also an indispensable tool in tracking tumor progression or its response to treatment. As these imaging studies are non-invasive, relatively cheap and accessible to patients, there have been many efforts over the past two decades to increase the amount of clinically-relevant information that can be extracted from brain imaging. Most recently, artificial intelligence (AI) techniques have been employed to segment and characterize brain tumors, as well as to detect progression or treatment-response. However, the clinical utility of such endeavours remains limited due to challenges in data collection and annotation, model training, and the reliability of AI-generated information.
We provide a review of recent advances in addressing the above challenges. First, to overcome the challenge of data paucity, different image imputation and synthesis techniques along with annotation collection efforts are summarized. Next, various training strategies are presented to meet multiple desiderata, such as model performance, generalization ability, data privacy protection, and learning with sparse annotations. Finally, standardized performance evaluation and model interpretability methods have been reviewed. We believe that these technical approaches will facilitate the development of a fully-functional AI tool in the clinical care of patients with gliomas.
△ Less
Submitted 10 April, 2020; v1 submitted 28 November, 2019;
originally announced November 2019.
